Impact News +++ SAP Aktie mit Kaufsignal: Zahlen und ein erhöhter Ausblick für 2021 (4investors) +++ SAP Aktie +3,07%

ONCTERNAL Aktie

 >ONCTERNAL Aktienkurs 
5.38 EUR    +0.3%    (Tradegate)
Ask: 5.64 EUR / 542 Stück
Bid: 5.38 EUR / 569 Stück
Tagesumsatz: 1050 Stück
Realtime Kurs von 8 bis 22 Uhr!
>ONCTERNAL Performance
1 Woche: -27,1%
1 Monat: -13,5%
3 Monate: +26,1%
6 Monate: +241,0%
1 Jahr: +112,0%
laufendes Jahr: +36,1%
>ONCTERNAL Aktie
Name:  ONCTERNAL THERAP. DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US68236P1075 / A2PL3P
Symbol/ Ticker:  GTU2 (Frankfurt) / ONCT (NASDAQ)
Kürzel:  FRA:GTU2, GTU2.F, GTU2:GR, NASDAQ:ONCT
Index:  -
Webseite:  https://www.oncternal.com..
Marktkapitalisierung:  342.21 Mio. EUR
Umsatz:  2.84 Mio. EUR
EBITDA:  -
Gewinn je Aktie:  -0.597 EUR
Schulden:  0.03 Mio. EUR
Liquide Mittel:  98.1 Mio. EUR
Umsatz-/ Gewinnwachstum:  115.8% / -
KGV/ KGV lG:  - / -11.01
KUV/ KBV/ PEG:  101.39 / 2.85 / -
Gewinnm./ Eigenkapitalr.:  - / -27.07%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  ONCTERNAL
Letzte Datenerhebung:  11.04.21
>ONCTERNAL Eigentümer
Aktien: 49.28 Mio. St.
f.h. Aktien: 43.5 Mio. St.
Insider Eigner: 14.82%
Instit. Eigner: 21.61%
Leerverk. Aktien: 0.47%
>ONCTERNAL Peer Group

 
12.04.21 - 22:45
Oncternal Therapeutics Announces Appointment of Chase Leavitt as General Counsel (GlobeNewswire EN)
 
SAN DIEGO, April 12, 2021 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the appointment of Chase Leavitt as Genera...
12.04.21 - 15:18
Oncternal Therapeutics down 8% despite promising cirmtuzumab results in broad cancer indications (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.04.21 - 13:03
Oncternal Therapeutics Announces Presentation of Three Posters at AACR 2021 Virtual Meeting (GlobeNewswire EN)
 
SAN DIEGO, April 12, 2021 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the presentation of three posters at the A...
09.04.21 - 12:03
Oncternal Therapeutics′ (ONCT) Shares March Higher, Can It Continue? (Zacks)
 
As of late, it has definitely been a great time to be an investor in Oncternal Therapeutics, Inc. (ONCT)....
08.04.21 - 14:21
Zacks.com featured highlights include: Avid Bioservices, Oncternal Therapeutics, Amtech Systems and Aytu Biopharma (Zacks)
 
Zacks.com featured highlights include: Avid Bioservices, Oncternal Therapeutics, Amtech Systems and Aytu Biopharma...
08.04.21 - 11:21
Oncternal Therapeutics (ONCT) Soars 8.4%: Is Further Upside Left in the Stock? (Zacks)
 
Oncternal Therapeutics (ONCT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term....
07.04.21 - 22:14
Oncternal Therapeutics Jumps on Bullish Oppenheimer Initiation (The Street)
 
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...
07.04.21 - 21:54
Why Oncternal Therapeutics Stock Is Popping Today (Fool)
 
This analyst is excited about the company's prospects....
07.04.21 - 16:48
Oppenheimer sees ~62% rise in shares of Oncternal Therapeutics (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.04.21 - 16:03
Analyzing The Price Action In Oncternal Therapeutics Stock Today (Benzinga)
 
Oncternal Therapeutics's Stock Price And Volume Action Oncternal Therapeutics's (NASDAQ:ONCT) stock has been rising Wednesday, up 4.61% to a price of $9.13. The stock's volume is currently 126.68 thousand, which is roughly 8.74% of its recent 30-...
07.04.21 - 15:07
5 Stocks to Buy on New Analyst Coverage (Zacks)
 
Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Interactive Brokers (IBKR), Avid (CDMO), Oncternal (ONCT), Amtech (ASYS) and Aytu....
05.04.21 - 15:06
Implied Volatility Surging for Oncternal Therapeutics (ONCT) Stock Options (Zacks)
 
Investors need to pay close attention to Oncternal Therapeutics (ONCT) stock based on the movements in the options market lately....
01.04.21 - 08:51
Oncternal Therapeutics: Opportunistic Investment In A ROR-1 Biotech (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
19.03.21 - 19:30
Oncternal Therapeutics, Inc. (ONCT) Q4 2020 Earnings Call Transcript (Fool)
 
ONCT earnings call for the period ending December 31, 2020....
18.03.21 - 21:42
Oncternal Therapeutics Reports Granting of an Inducement Award Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
 
SAN DIEGO, March 18, 2021 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it has granted an inducement award to...
17.03.21 - 16:00
Analyzing The Price Action In Oncternal Therapeutics Stock Today (Benzinga)
 
The Price And Volume Action In Oncternal Therapeutics's Stock Today Oncternal Therapeutics's (NASDAQ:ONCT) stock has been rising Wednesday, up 7.54% to a price of $9.06. Wednesday the stock has been traded at a volume of 949.72 thousand, about 65....
14.03.21 - 14:51
Oncternal Therapeutics (ONCT) Investor Presentation - Slideshow (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.03.21 - 03:48
Oncternal Therapeutics, Inc. (ONCT) CEO Jim Breitmeyer on Q4 2020 Results - Earnings Call Transcript (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Zitat des Tages: Urteilskraft ist nicht bei jeder Gelegenheit erforderlich, Takt aber immer. - Philip Dormer Stanhope
Partner:    >Tradegate Börse | >TraderFox Handelssignale | >Heibel-Ticker Börsenbrief | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf Twitter | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!